Journal article icon

Journal article

Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.

Abstract:

Follicular lymphoma (FL) is an indolent B-cell malignancy with a variable course. Standard immuno-chemotherapy incorporate alkylator and anti-CD20 monoclonal antibody as first line (Rummel et al, 2013) commonly followed by 24 months rituximab maintenance (Salles et al, 2008). Anthracycline, purine analogue, and alkylator combination are used at relapse and younger patients may have remissions consolidated with autologous or allogeneic stem-cell transplantation (alloSCT) (Kothari et al, 2014)....

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1111/bjh.14665

Authors


Expand authors...
Publisher:
Wiley Publisher's website
Journal:
British Journal of Haematology Journal website
Publication date:
2017-03-01
Acceptance date:
2017-02-27
DOI:
EISSN:
1365-2141
ISSN:
0007-1048
Source identifiers:
688793
Language:
English
Keywords:
Pubs id:
pubs:688793
UUID:
uuid:03900685-578c-4839-add9-e27317d4b964
Local pid:
pubs:688793
Deposit date:
2017-05-26

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP